Atomera (ATOM) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
Significant progress in MST technology development, customer engagement, and industry collaborations, with momentum for transformative deals and new license agreements across multiple semiconductor segments.
Focus on MST transistor enhancement technology targeting the $550–$600B semiconductor market, with a high-leverage IP licensing model and a strong patent portfolio.
Collaborates with leading semiconductor manufacturers, including 50% of the world's top makers, and maintains active customer pipeline and advanced negotiations.
ST Microelectronics partnership remains on track, with milestone-based revenue and potential for high-margin royalties upon product qualification.
Management anticipates accelerated customer engagements and potential new licenses and JDAs in the near term, supported by recent collaborations and technology presentations.
Financial highlights
Q3 2024 revenue was $22,000, down from $72,000 in Q2 2024 and $112,000 in Q3 2023.
Q3 2024 GAAP net loss was $4.6 million ($0.17/share), improved from $5 million ($0.20/share) in Q3 2023.
Adjusted EBITDA loss for Q3 2024 was $3.9 million, compared to $4.3 million in Q3 2023.
Operating expenses for Q3 2024 were $4.8 million, down from $5.4 million in Q3 2023, mainly due to lower R&D and sales/marketing costs.
Cash, cash equivalents, and short-term investments totaled $17.3 million at quarter-end.
Outlook and guidance
Q4 2024 revenue expected to be similar to Q3; no guidance beyond Q4 provided.
Full-year 2024 non-GAAP OpEx projected at $15.75–$16 million, below prior guidance; 2025 non-GAAP OpEx expected to rise to $16–$17 million.
Management believes available working capital is sufficient to fund operations for at least the next 12 months.
Next major revenue milestone tied to ST's completion of qualification, with timing under ST's control.
Future capital needs depend on commercialization success, market developments, and potential collaborations or acquisitions.
Latest events from Atomera
- Virtual meeting to vote on directors, auditor, share increase, and executive pay; strong governance focus.ATOM
Proxy Filing17 Mar 2026 - Technical advances and new customer traction amid losses and strong industry demand.ATOM
Q4 202513 Feb 2026 - Q2 2024 net loss narrowed, revenue rose, and MST technology advances amid ongoing risks.ATOM
Q2 20242 Feb 2026 - MST drives performance gains for semiconductors, targeting growth through licensing and industry alliances.ATOM
27th Annual Needham Growth Conference10 Jan 2026 - At-the-market offering of up to $50M in stock to fund growth, with significant dilution risk.ATOM
Registration Filing16 Dec 2025 - 2024 saw improved cash, narrowed net loss, and expanded MST engagement despite minimal revenue.ATOM
Q4 20243 Dec 2025 - Virtual meeting to vote on directors, auditor, executive pay, and stock plan amendment.ATOM
Proxy Filing1 Dec 2025 - Amendment to the 2023 Stock Incentive Plan and CEO severance terms up for shareholder vote.ATOM
Proxy Filing1 Dec 2025 - Shareholders to vote on amending the 2023 Stock Incentive Plan at the 2025 Annual Meeting.ATOM
Proxy Filing1 Dec 2025